Synergistic action of lactoferrin and its derived functional fragments as a promising therapeutic agent in combating mucormycosis

S Pandit, A Singh, J Singh, I Xess, TP Singh… - Future …, 2024 - Taylor & Francis
Aim: Currently, we have limited armamentarium of antifungal agents against Mucorales.
There is an urgent need to discover novel antifungal agents that are effective, safe and …

Lactoferrin, a potential iron-chelator as an adjunct treatment for mucormycosis–a comprehensive review

A Singh, N Ahmad, A Varadarajan, N Vikram… - International Journal of …, 2021 - Elsevier
Mucormycosis is a deadly infection which is caused by fungi of the order Mucorales
including species belonging to the genus Rhizopus, Mucor, Mycocladus, Rhizomucor …

Promising Antifungal Molecules against Mucormycosis Agents Identified from Pandemic Response Box®: In Vitro and In Silico Analyses

MIDS Xisto, R Rollin-Pinheiro, Y de Castro-Almeida… - Journal of Fungi, 2023 - mdpi.com
Mucormycosis is considered concerning invasive fungal infections due to its high mortality
rates, difficult diagnosis and limited treatment approaches. Mucorales species are highly …

Advancements in the understanding of Mucorales biology and the management of mucormycosis

G Chamilos, V Garre - Frontiers in Cellular and Infection Microbiology, 2024 - frontiersin.org
Mucormycosis is a life-threatening infection caused by certain species of the fungal order
Mucorales. Although respiratory tract is the primary site of infection by Mucorales …

Current treatments against mucormycosis and future directions

C Smith, SC Lee - PLoS Pathogens, 2022 - journals.plos.org
Mucormycosis (previously called zygomycosis) is a serious but rare fungal infection caused
by a group of fungi belonging to the order Mucorales. These molds exist throughout the …

[PDF][PDF] A Comprehensive Review on Mucormycosis

M Rathod, J Patel, M Prajapati, M Oza - Int. j. pharm. res. appl, 2022 - researchgate.net
Aside from its history the incidence and pattern of mucormycosis have increased by the
impression of Covid-19. Mucormycosis is the third most prevalent invasive fungal infection in …

Combination therapy in Mucormycosis: Current evidence from the world literature, a mini review

DS Meena, D Kumar, GK Bohra - Journal of Medical Mycology, 2023 - Elsevier
The emergence of Mucorales infections is an urgent global public health threat rapidly
disseminating during the current COVID-19 pandemic. Invasive mucormycosis carries …

Molecular mechanisms of antifungal resistance in mucormycosis

P Ganesan, D Ganapathy, S Sekaran… - BioMed Research …, 2022 - Wiley Online Library
Mucormycosis is one among the life‐threatening fungal infections with high morbidity and
mortality. It is an uncommon and rare infection targeting people with altered immunity. This …

[HTML][HTML] Antifungal activity of Taurolidine against Mucorales: An in vitro study on clinical isolates

H Jafarian, A Amanati, P Badiee - Current Medical Mycology, 2022 - ncbi.nlm.nih.gov
Background and Purpose: Taurolidine is active against a wide variety of micro-organisms,
including bacteria and fungi. Mucormycosis is one of the life-threatening opportunistic fungal …

An extensive review on antifungal approaches in the treatment of mucormycosis

HS Chaudhari, OS Palkar… - … of Biochemical and …, 2023 - Wiley Online Library
During the period of COVID‐19, the occurrences of mucormycosis in immunocompromised
patients have increased significantly. Mucormycosis (black fungus) is a rare and rapidly …